ConductScience.org, home

Paper3146972

Kinetic analysis of the interaction between plasminogen activator inhibitor-1 and tissue-type plasminogen activator.

Masson C and 1 other. Biochem J, 1988. Cited by 35 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Kinetic analysis of the interaction between plasminogen activator inhibitor-1 and tissue-type plasminogen activator. Papers, record 3146972. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3146972

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Kinetic analysis of the interaction between plasminogen activator inhibitor-1 and tissue-type plasminogen activator.
PubMed
Journal
Biochem J
PubMed
Year
1988
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
35
iCite
Relative citation ratio, by iCite
1.19
iCite
Revised in PubMed
2019-05-01
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Masson CC
2Angles-Cano EE

Source PubMed

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
GlycoproteinsMajor topic
Tissue Plasminogen ActivatorMajor topic
Cells, Cultured
Electrophoresis, Polyacrylamide Gel
Endothelium
Fibrin
Humans
Kinetics
Macromolecular Substances
Plasminogen
Plasminogen Inactivators

Source PubMed

References36

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
15,639,129Urokinase inhibitor in human placenta.Nature1968https://conductscience.org/library/papers/5639129PubMed
2637,870Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril.Biochem Biophys Res Commun1978https://conductscience.org/library/papers/637870PubMed
34,257,942Characterization of human plasminogen. II. Separation and partial characterization of different molecular forms of human plasminogen.Biochim Biophys Acta1972https://conductscience.org/library/papers/4257942PubMed
44,672,651Differences in the binding to fibrin of urokinase and tissue plasminogen activator.Thromb Diath Haemorrh1972https://conductscience.org/library/papers/4672651PubMed
54,355,998Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria.J Clin Invest1973https://conductscience.org/library/papers/4355998PubMed
6147,769On the kinetics of the reaction between human antiplasmin and plasmin.Eur J Biochem1978https://conductscience.org/library/papers/147769PubMed
7653,632Production of a fibrinolytic inhibitor by cultured endothelial cells derived from human umbilical vein.Thromb Res1978https://conductscience.org/library/papers/653632PubMed
86,787,058Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture.J Biol Chem1981https://conductscience.org/library/papers/6787058PubMed
96,171,907Neutralization of human extrinsic (tissue-type) plasminogen activator in human plasma: no evidence for a specific inhibitor.Thromb Haemost1981https://conductscience.org/library/papers/6171907PubMed
107,199,524Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin.J Biol Chem1982https://conductscience.org/library/papers/7199524PubMed
116,294,098Protein C inhibitor. Purification from human plasma and characterization.J Biol Chem1983https://conductscience.org/library/papers/6294098PubMed
126,574,465Detection of an unusually stable fibrinolytic inhibitor produced by bovine endothelial cells.Proc Natl Acad Sci U S A1983https://conductscience.org/library/papers/6574465PubMed
136,635,659Human endothelial cells: use of heparin in cloning and long-term serial cultivation.Science1983https://conductscience.org/library/papers/6635659PubMed
146,580,616Latent tissue plasminogen activator produced by human endothelial cells in culture: evidence for an enzyme-inhibitor complex.Proc Natl Acad Sci U S A1983https://conductscience.org/library/papers/6580616PubMed
156,423,634Inactivation of tissue plasminogen activator in plasma. Demonstration of a complex with a new rapid inhibitor.J Biol Chem1984https://conductscience.org/library/papers/6423634PubMed
166,430,331Differential inhibition of two molecular forms of melanoma cell plasminogen activator by a placental inhibitor.Br J Haematol1984https://conductscience.org/library/papers/6430331PubMed
176,434,006Demonstration of a fast-acting inhibitor of plasminogen activators in human plasma.Blood1984https://conductscience.org/library/papers/6434006PubMed
186,435,684Isolation of tissue-type plasminogen activator-inhibitor complexes from human plasma. Evidence for a rapid plasminogen activator inhibitor.Biochim Biophys Acta1984https://conductscience.org/library/papers/6435684PubMed
196,435,688Human endothelial cells produce a plasminogen activator inhibitor and a tissue-type plasminogen activator-inhibitor complex.Biochim Biophys Acta1984https://conductscience.org/library/papers/6435688PubMed
206,437,006Evidence for the occurrence of a fast-acting inhibitor for tissue-type plasminogen activator in human plasma.Thromb Haemost1984https://conductscience.org/library/papers/6437006PubMed

See all 36 references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.

PMIDTitleJournalYearIn PapersSource
38,004,336Fibrin and Fibrinolytic Enzyme Cascade in Thrombosis: Unravelling the Role.Life (Basel)2023https://conductscience.org/library/papers/38004336PubMed
19,672,469Obesity and breast cancer: the roles of peroxisome proliferator-activated receptor-γ and plasminogen activator inhibitor-1.PPAR Res2009https://conductscience.org/library/papers/19672469PubMed
7,745,468Modulation of fibrinolysis by ionizing radiation.J Neurooncol1994https://conductscience.org/library/papers/7745468PubMed
1,699,517The mechanism of activation of plasminogen at the fibrin surface by tissue-type plasminogen activator in a plasma milieu in vitro. Role of alpha 2-antiplasmin.Biochem J1990https://conductscience.org/library/papers/1699517PubMed

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
PLAT5,327PubTator's text mininghttps://conductscience.org/library/genes/5327NCBI Gene
PLG5,340PubTator's text mininghttps://conductscience.org/library/genes/5340NCBI Gene
SERPINE15,054PubTator's text mininghttps://conductscience.org/library/genes/5054NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3146972

GET https://conductscience.org/api/papers/v1/3146972/references?page=2